Themis Medicare Limited — Updates, 18-11-2024: Press Release

Gujarat Themis Biosyn Limited and Themis Medicare Limited have approved a Scheme of Amalgamation that aims to consolidate their businesses and integrate their product value chain into a single entity. This strategic move is anticipated to generate significant synergies. As part of the scheme, TML will issue 118 equity shares for every 100 equity shares held by GTBL shareholders, evaluated at the face value of Re. 1 each. The transaction is contingent upon approvals from secured creditors, shareholders, stock exchanges, SEBI, NCLT, and other regulatory bodies. This amalgamation positions the combined entity to enhance operational efficiencies and drive growth. Investors should monitor this development closely as it could reshape the competitive landscape for both companies.